cas 131748-14-6|| where to buy 4-Chloro-2-(trifluoromethyl)pyridine

Nombre del producto:4-Chloro-2-(trifluoromethyl)pyridine

IUPAC Name:4-chloro-2-(trifluoromethyl)pyridine

Unidad de embalaje	Stock disponible	Precio($)
CM120691-25g	in stock	Ǡœ
CM120691-100g	in stock	ƅƩƅ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 131748-14-6 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :131748-14-6; Fórmula molecular:C6H3ClF3N; Punto de fusión:-; Código de sonrisas:FC(C1=NC=CC(Cl)=C1)(F)F; Densidad:

: Número de catálogo:CM120691; Peso molecular:181.54; Punto de ebullición:; Nº Mdl:MFCD07368047; Almacenamiento:

: Pyridines; Pyridine is a six-membered heterocyclic compound containing one nitrogen heteroatom. Pyridine and piperidine are the most frequently occurring heterocyclic building blocks in drug molecules. According to incomplete statistics, there are currently more than 180 drugs containing pyridine or piperidine structure that have been marketed, nearly 1/5 of the drugs approved for marketing in recent years contain these two structures.; Pyridine | C5H5N | Pyridine Supplier/Distributor/Manufacturer - Chemenu; Pyridine,Pyridine Wholesale,Pyridine for Sale,Pyridine Supplier,Pyridine Distributor,Pyridine Manufacturer; Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N. It is structurally related to benzene, with one methine group (=CH−) replaced by a nitrogen atom. It is a highly flammable, weakly alkaline, water-miscible liquid with a distinctive, unpleasant fish-like smell.

: Emraclidine; Emraclidine is a novel, brain-penetrant, highly selective M4 receptor positive allosteric modulator(PAM) in development for the treatment of schizophrenia.
We believe emraclidine has the potential to provide a significant medical advancement as the muscarinic acetylcholine pathway has long been associated with mediation of neurotransmitter imbalance and psychosis. Emraclidine is the only selective M4 receptor PAM currently in clinical development.